TNFSF10 and non-small cell lung carcinoma: Significantly higher cell viability was observed in MSC-TRAIL when compared to the NSCLC cells lines for all the 5-FU dosages, suggesting that MSC-TRAIL was less sensitive to the 5-FU treatment (Figure 2B).